Hepatitis Forums
Hepatitis C Main Forums => Hepatitis C Research News & Studies => Topic started by: Hep Editors on February 24, 2020, 01:31:10 pm
-
People who currently use drugs or have a history of doing so, including those taking medication-assisted treatment (MAT) to treat opioid use disorder, have a high hepatitis C virus (HCV) cure rate following direct-acting antiviral treatment with Mavyret (glecaprevir/pibrentasvir).
Mavyret is approved to treat all genotypes of HCV and can be used in combination with MAT. The regimen can be completed in as little as eight weeks, including among those with compensated cirrhosis (the milder form of the severe liver disease).
Alessio Aghemo, MD, of Humanitas University and Research Hospital in Rozzano, Italy, presented results from a pooled analysis of clinical trials and real-world studies of Mavyret at The Liver Meeting, the Annual Meeting of the American Association for the Study of Liver Diseases, in Boston this month.
Read more...
https://www.hepmag.com/article/mavyret-highly-effective-hep-c-druguse-history